Browse All

Current Filters

CLEAR FILTER x

TITLE

A Longitudinal Quantitative Assessment of Phosphorylated Alpha-Synuclein Deposition in Dementia with Lewy Bodies

Author:Gibbons, Christopher   Levine, Todd   Bellaire, Bailey   Freeman, Roy   

Session Name:S1: Innovations in Non-AD Dementia  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:S1.007  

Author Institution:Beth Israel Deaconess Medical Center, Boston, MA  Honor Health, Scottsdale, AZ  CND Life Sciences, Scottsdale, AZ  Beth Israel Deaconess Hosp, Boston, MA  

The Syn-D Study: Detection of Cutaneous Phosphorylated Alpha-Synuclein and blood P-Tau 217 in Patients with Mild Cognitive Impairment

Author:Gibbons, Christopher   Levine, Todd   Bellaire, Bailey   Freeman, Roy   

Session Name:S1: Innovations in Non-AD Dementia  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:S1.008  

Author Institution:Beth Israel Deaconess Medical Center, Boston, MA  Honor Health, Scottsdale, AZ  CND Life Sciences, Scottsdale, AZ  Beth Israel Deaconess Hosp, Boston, MA  

Association of Cortical Superficial Siderosis with Poor Functional Outcomes Following Cerebral Amyloid Angiopathy-Related Hemorrhage

Author:Das, Alvin   Abramovitz, Avia   Gokcal, Elif   Rotschild, Ofer   Regenhardt, Robert   Selim, Magdy   Viswanathan, Anand   Goldstein, Joshua   Rosand, Jonathan   Greenberg, Steven   Gurol, M. Edip   

Session Name:S2: Advances in Stroke Imaging and Biomarkers  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:S2.003  

Author Institution:Beth Israel Deaconess Medical Center, Boston, MA  Massachusetts General Hospital, Boston, MA  

Compound 2a Protects Against Dopaminergic Neuronal Degeneration in a Mouse Model of Parkinson’s Disease

Author:Persico, Michele   Zhang Fang, Tracy Shi   Eleuteri, Simona C.   Simon, David   

Session Name:S4: Movement Disorders: Basic Science  

Topic:Movement Disorders  

Program Number:S4.007  

Author Institution:BIDMC, Harvard University, Atlanta, GA  BIDMC, Harvard University, Boston, MA  Beth Israel Deaconess Medical Center, Boston, MA  

Suzetrigine, a Selective Pain Signal Inhibitor of NaV1.8 Shows Proof-of-concept for Treatment of Painful Diabetic Peripheral Neuropathy

Author:Freeman, Roy   Rauck, Richard   Argoff, Charles   Tian, Simon   Miao, Xiaopeng   Bouldin Olivet, Hannah   Bozic, Carmen   Dworkin, Robert   

Session Name:S11: Pain  

Topic:Pain  

Program Number:S11.002  

Author Institution:Beth Israel Deaconess Medical Center, Boston, MA  Carolinas Pain Institute, Winston-Salem, NC  Albany Medical College, Albany, NY  Vertex Pharmaceuticals, Boston, MA  University of Rochester School of Medicine and Dentistry, Rochester, NY